News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Toll Brothers released a new four-story townhome building at Iron Creek in Charlotte, with units starting in the low $400,000s near Uptown.
  • Options traders skewed bullish on AEO ahead of earnings, trading 27,917 contracts with a 2.1:1 call/put ratio and active Sept. 18 $17.50 calls.
  • Options imply roughly a ±13% move for AEO's post-close Sept. 9 earnings, and recent quarters have often exceeded those implied ranges.
  • Meta launched Muse, an AI agent that operates across apps, available in the U.S. via a standalone app and WhatsApp.
  • Each Muse agent runs in an isolated virtual machine and Meta says users control which apps it can access.
  • Internal tests reportedly showed failures, unauthorized uploads, and workarounds exposing private photos despite a delayed release for safety fixes.

Latest Articles

WeShop First Half 2026 Financial Results Available on its Website

WeShop First Half 2026 Financial Results Available on its Website

WeShop Holdings Limited announced its financial results for the first half of 2026, which are available on its Investor Relations website and submitted to the SEC via Form 6-K. The company continues to operate as a social-commerce platform merging shopping, sharing, and investing with a proprietary equity-sharing program. Forward-looking statements…

Orangekloud Technology Inc. Enters into Definitive Agreement to Acquire Orbis Technology Limited, Operator of VeVe

Orangekloud Technology Inc. Enters into Definitive Agreement to Acquire Orbis Technology Limited, Operator of VeVe

Orangekloud Technology Inc., a Nasdaq-listed Singapore-based technology company, announced a definitive agreement to acquire Orbis Technology Limited, operator of VeVe, the leading mobile-first digital collectibles platform. Post-acquisition, the company will be renamed VeVe Inc. and continue trading on Nasdaq under the ticker symbol "VEVE." The tr…

FingerMotion CEO Jolie Kahn Issues Letter to Shareholders

FingerMotion CEO Jolie Kahn Issues Letter to Shareholders

FingerMotion CEO Jolie Kahn presents a strategic letter to shareholders detailing the company's shift towards modular, behind-the-meter AI and high-performance computing in North America. The plan emphasizes measured growth, commercial validation, disciplined capital deployment, and strengthening existing operations in China. Recent acquisition of …

LPL Financial Appoints Jonathan Lewis as Managing Director, Chief Technology and Information Officer

LPL Financial Appoints Jonathan Lewis as Managing Director, Chief Technology and Information Officer

LPL Financial has appointed Jonathan Lewis as Managing Director, Chief Technology and Information Officer. Lewis brings over 20 years of experience from major financial institutions like Wells Fargo and J.P. Morgan. His role will focus on leading technology architecture, engineering, infrastructure, and development to accelerate innovation, AI inte…

Xanadu Announces Technological Roadmap Presentation

Xanadu Announces Technological Roadmap Presentation

Xanadu Quantum Technologies, a leading Canadian photonic quantum computing company, announced a live Technological Roadmap Presentation scheduled for August 31, 2026. The event will provide investors and analysts with insights into the company's development plans toward building large-scale fault-tolerant quantum computers operating at room tempera…

Longeveron Announces 1-for-10 Reverse Stock Split

Longeveron Announces 1-for-10 Reverse Stock Split

Longeveron Inc., a clinical-stage biotechnology company, announced a 1-for-10 reverse stock split of its Class A and Class B common stock effective August 26, 2026. The move is intended to increase the per-share trading price to regain compliance with Nasdaq's $1.00 minimum bid price requirement and better align its share structure with institution…

Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026

Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026

Avalyn Pharma announced two upcoming poster presentations at the European Respiratory Society International Congress 2026, highlighting patient perspectives on clinical trial participation and novel inhaled formulations of pirfenidone for pulmonary fibrosis. The presentations emphasize their advancing inhaled therapies aiming to improve efficacy an…

Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Oruka Therapeutics has appointed Todd Edwards as Chief Commercial Officer to lead the commercialization efforts of its novel biologics targeting chronic skin diseases such as plaque psoriasis and hidradenitis suppurativa. Edwards brings over 25 years of experience in immunology and dermatology sectors, having held senior commercial roles at several…

Coda Octopus Group Announces Fiscal Third Quarter 2026 Earnings Conference Call for September 14, 2026, at 10:00 a.m. Eastern Time

Coda Octopus Group Announces Fiscal Third Quarter 2026 Earnings Conference Call for September 14, 2026, at 10:00 a.m. Eastern Time

Coda Octopus Group, Inc. announced a conference call on September 14, 2026, to discuss its financial results for the fiscal third quarter ended July 31, 2026. The company, known for its advanced real-time imaging sonar and augmented reality diving technology, aims to update investors on its performance and recent acquisition, Precision Acoustics Li…

Belite Bio to Host Virtual Commercial Day on September 2, 2026

Belite Bio to Host Virtual Commercial Day on September 2, 2026

Belite Bio announced a Virtual Commercial Day on September 2, 2026, focusing on its lead drug candidate tinlarebant for Stargardt disease type 1 (STGD1). The company provided updates on the FDA's Priority Review acceptance of its New Drug Application, prelaunch strategies, and commercial opportunities pending approval. Tinlarebant has shown promisi…

Alpha Compute Continues to Grow Technical Execution and Client Support Teams for Scaling Global AI Infrastructure Business

Alpha Compute Continues to Grow Technical Execution and Client Support Teams for Scaling Global AI Infrastructure Business

Alpha Compute Corp., a Nasdaq-listed AI infrastructure company, announced key executive appointments to enhance technical execution and client support in its growing Global Infrastructure Business. The new leadership aims to optimize AI compute deployments, drive enterprise client success, and scale the company's Blackwell-class GPU fleet to meet a…

Western Digital: Buy the Pullback Ahead of the Next AI-Driven Leg Higher

Western Digital: Buy the Pullback Ahead of the Next AI-Driven Leg Higher

Western Digital (WDC) just sold off into a constructive area after a strong earnings print and bullish guidance. The company trades with healthy cash flow, low leverage and high ROE while hyperscaler demand for storage remains the dominant fundamental driver. This trade idea outlines an entry at $440.00, a stop at $385.00, and a target at $560.00 o…

Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories

Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories

Cosmos Health Inc. projects its nutraceutical product Oliv18™ will generate more than $6 million in incremental annual revenue and $4.3 million in gross profit in the U.S. within 12 to 18 months. The product, part of the Company's 18 Series, targets the cardiovascular health and antioxidant categories, markets valued in the billions and expected to…

Arlo: Subscriber Momentum Justifies a Long — Play the SaaS Conversion

Arlo: Subscriber Momentum Justifies a Long — Play the SaaS Conversion

Arlo's transition to a subscription-first model is driving meaningful revenue mix improvement and predictable cash flow. With subscriptions reported at >60% of revenue in the last reported quarter and free cash flow positive, the stock at ~$13 offers a structured long trade that targets the prior regime highs while keeping a clear stop beneath the …